Feb 26-28 2024
INOVOTION will be present at the ESMO – European Society for Medical Oncology Targeted Anticancer Therapies Congress 2024 in Paris– February 26-28 in Paris!
ESMO-TAT offers participants a glimpse into the future of anticancer therapies, focusing on promising new targets and agents, with a particular emphasis on early drug development. It’s of interest for both academic and industry participants.
Sales Director Arnaud Peyronnier, Business Developer Solène Robert, and R&D Project Manager Chloé Prunier will join leading biotech and pharma executives to discuss the latest preclinical testing trends.
We look forward to meeting you there and discussing your future projects!
Nov 13
2024
Come see us at the EPAA
Come see us at the EPAA (European Partnership for Alternative Approaches to Animal Testing) 2024 Annual Conference INOVOTION will be at the European Partnership for Alternative Approaches to Animal Testing (EPAA) Annual Conference 2024, November […]
Nov 6-10
2024
Come see us at the SITC
Come see us at the SITC (Society for Immunotherapy of Cancer) 39th Annual Meeting, November 6-10, 2024, in Houston! SITC 2024 is the world’s leading showcase of advances in cancer immunology and immunotherapy, bringing together […]
Nov 4-6
2024
Come see us at Bio-Europe Fall
